AmbioPharm

AmbioPharm is a globally recognized contract development and manufacturing organization (CDMO) headquartered in North Augusta, SC, specializing exclusively in peptide active pharmaceutical ingredients (APIs). As one of the world's largest peptide CDMOs, AmbioPharm has built an exceptional reputation by partnering with pharmaceutical and biotech companies at every stage of the development lifecycle, from early-stage synthesis through full-scale commercial production. With a team of more than 500 chemists and a state-of-the-art cGMP-compliant facility, AmbioPharm stands as a premier research laboratory in North Augusta delivering the scientific depth and operational scale that drug developers demand.

AmbioPharm offers a comprehensive suite of peptide manufacturing and development services tailored to the rigorous demands of modern pharmaceutical research. Their GMP service offerings include custom peptide synthesis, custom organic synthesis, GMP manufacturing of late-stage peptide APIs, and biologically active peptide production. Beyond GMP scope, AmbioPharm extends its capabilities into vaccine services, cosmetic peptide manufacturing, and robust analytical development and validation programs. For research labs and pharmaceutical partners seeking end-to-end peptide solutions, AmbioPharm functions as a true full-service research laboratory equipped to handle complex synthesis challenges with precision and consistency across all project scales.

Within the competitive landscape of peptide CDMOs, AmbioPharm holds a distinguished position as one of the industry's largest and most experienced organizations, serving clients with national reach across the United States and beyond. Their client base spans emerging biotech startups and established multinational pharmaceutical companies alike, reflecting the versatility and reliability that research labs and drug developers require when selecting a long-term manufacturing partner. AmbioPharm's ability to support projects from development through commercial-scale production under a single roof gives partners a significant strategic advantage in bringing peptide-based therapeutics and products to market efficiently.

For industry professionals evaluating research labs and CDMOs, quality assurance and regulatory compliance are non-negotiable priorities. AmbioPharm's FDA-inspected cGMP facility has successfully passed five FDA inspections, demonstrating a sustained commitment to quality systems, documentation integrity, and manufacturing compliance that pharmaceutical and biotech partners can rely on. Their dedicated quality and compliance infrastructure, combined with transparent FDA inspection history, positions AmbioPharm as one of the most rigorously vetted research laboratory operations in North Augusta and across the national peptide manufacturing sector. These quality benchmarks provide the assurance that research labs and development teams need when entrusting critical API manufacturing to an outside partner.

Industry professionals, pharmaceutical scientists, and biotech developers looking for a proven peptide manufacturing partner are encouraged to connect with AmbioPharm directly to discuss project requirements, timelines, and capabilities. Whether a project is in early feasibility or approaching commercial scale, the expert team at AmbioPharm is prepared to provide guidance and develop a customized manufacturing strategy. As a leading research laboratory in North Augusta with a global reputation and national service reach, AmbioPharm welcomes inquiries from research labs and pharmaceutical organizations ready to advance their peptide programs with a trusted, FDA-inspected CDMO.